Schizophrenia

The U.S. Food and Drug Administration (FDA) has approved Aristada Initio (aripiprazole lauroxil) to begin the development of Aristada, a long-acting injectable unusual antipsychotic, to treat schizophrenia in adults. The move will now make it possible to dose patients with Aristada Initio in combination with a single 30 mg dose of oral aripiprazole as an […]

A physician-scientist from the University of Arizona College of Medicine, Phoenix, recently received a $175,000 grant from the reputed Sidney R. Baer, Jr. Foundation to develop the first diagnostic test for schizophrenia. The Sidney R. Baer Foundation was established in 1999 and is the brainchild of Sidney Baer, a wealthy businessperson, who had struggled with schizophrenia […]

A research team from the University of Queensland in Australia has developed a new synthetic version of oxytocin, which may be used to treat mental health disorders like schizophrenia and anxiety without the risk of side effects. Researchers believe that being a naturally occurring hormone that acts as the brain’s neurotransmitter, oxytocin has the ability […]

On Sept. 5, 2017, at a conference of the European College of Neuropsychopharmacology in Paris, a team of scientists revealed that a certain part of the human brain is known to produce voices, which torment patients struggling with schizophrenia. The scientists also said that magnetic pulses can be used to mute the voices so that […]

The man accused of driving his car into a crowd holding an anti-fascist protest in Charlottesville, Virginia, on August 11, 2017, killing one woman and hurting at least 19 others, allegedly suffered from schizophrenia and was deeply influenced by Hitler, said one of his ex-teachers in school. James Alex Fields Jr., also stood out in […]